The development of standardized case definitions and guidelines for adverse events following immunization

Vaccine

Volumn 25, Issue 31, 2007, Pages 5671-5674

  Kohl, Katrin S ^a   Gidudu, Jane ^a   Bonhoeffer, Jan ^b   Braun, M Miles ^c   Buettcher, Michael ^b   Chen, Robert T ^a   Drammeh, Bakary ^a   Duclos, Philippe ^d   Heijbel, Harald ^e   Heininger, Ulrich ^b   Hummelman, Erik ^a   Jefferson, Thomas ^f   Keller Stanislawski, Brigitte ^g   Loupi, Elisabeth ^h   Marcy, S Michael ⁱ  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^f Vaccines Field   (Italy)

^g PAUL EHRLICH INSTITUT   (Germany)

^h SANOFI PASTEUR   (France)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

CASE DEFINITION; CASE STUDY; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL RESEARCH; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNIZATION; MEDICAL RESEARCH; POSTMARKETING SURVEILLANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; STANDARD; VACCINATION; VACCINATION REACTION; WORLD HEALTH ORGANIZATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; HUMANS; IMMUNIZATION PROGRAMS; PRACTICE GUIDELINES; REFERENCE STANDARDS; SAFETY; VACCINATION; VACCINES;

EID: 34447262157     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.02.063     Document Type: Editorial

References (27)

1. International Conference on Harmonization. The medical dictionary for regulatory activities. Available on the world wide web: http://www.ich.org/cache/compo/276-254-1.html and http://meddramsso.com/NewWeb2003/index.htm.
2. The Uppsala Monitoring Centre. WHO collaborating centre for international drug monitoring: adverse reaction terminology (WHO-ART). Available on the world wide web: http://www.who-umc.org/DynPage.aspx.
3. Vaccine Adverse Event Reporting System. Coding symbols for a thesaurus of adverse reaction terms (COSTART). Available on the world wide web: http://vaers.hhs.gov (last accessed March 30, 2006).
4. Council for International Organizations of Medical. Available on the world wide web: http://www.cioms.ch (last accessed March 30, 2006).
5. World Health Organization. Surveillance of adverse events following immunization. Field guide for managers of immunization programmes. Global Progamme for Vaccines and Immunization. Expanded Programme on Immunization. World Health Organization, Geneva, 1997. Report available on the world wide web at: http://www.who.int/vaccines-documents/DocsPDF/www9541.pdf.
6. Ball R., Halsey N., Braun M.M., Moulton L.H., Gale A.D., Rammohan K., et al. Development of case definitions for acute encephalopathy, encephalitis, and multiple sclerosis reports to the Vaccine Adverse Event Reporting System. J Clin Epidemiol 55 (2002) 819-824
7. Braun M.M., Terracciano G., Salive M.E., Blumberg D.A., Vermeer-de Bondt P.E., Heijbel H., et al. Report of a US public health service workshop on hypotonic-hyporesponsive episode (HHE) after pertussis immunization. Pediatrics 102 5 (1998) E52
8. Bonhoeffer J., Kohl K., Chen R.T., Duclos P., Heijbel H., Heininger U., et al. Standardized case definitions of adverse events following immunization (AEFI). Vaccine 22 (2004) 547-550
9. Kohl KS, Bonhoeffer J, Braun MM, Chen RT, Duclos P, Heijbel H, et al. A proposal for a global standard of case definitions (and guidelines) for adverse events following immunization. Advances in patient safety: from research to implementation. Vols. 1-4, AHRQ Publication Nos. 050021 (1-4). Rockville, MD: Agency for Healthcare Research and Quality; February 2005. Available on the world wide web: http://www.ahrq.gov/qual/advances/ (last accessed February 9, 2006).
10. Bonhoeffer J., Zumbrunn B., and Heininger U. Reporting of vaccine safety data in publications; systematic review. Pharmacoepidemiol Drug Saf 14 (2005) 101-106
11. The CONSORT Group. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 141 (2004) 781-788
12. Kohl K.S., Bonhoeffer J., Chen R., Duclos P., Heijbel H., Heininger U., et al. Enhancing comparability of vaccine safety data. Pharmacoepidemiol Drug Saf 12 (2003) 335-340
13. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Guidelines for clinical safety assessment (E2a-e). Available on the world wide web: http://www.ich.org/ (last accessed February 9, 2006).
14. Council for International Organizations of Medical Sciences (CIOMS). Reporting form for international reporting of adverse drug reactions. Available on the world wide web: http://www.cioms.ch/frame_what_is_cioms.htm (last accessed February 9, 2006).
15. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001; 285(15):1987-91. Available on the world wide web: http://www.consort-statement.org/Statement/revisedstatement.htm (last accessed February 9, 2006).
16. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 1999;354(November (9193)):1896-900. Also available on the world wide web: http://www.consort-statement.org/Initiatives/complements.htm (last accessed February 9, 2006).
17. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283(15):2008-12. Available on the world wide web: http://www.consort-statement.org/Initiatives/complements.htm (last accessed February 9, 2006).
18. Michael Marcy S., Kohl K.S., Dagan R., Nalin D., Blum M., Jones M.C., et al. Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 22 (2004) 551-556
19. Bonhoeffer J., Menkes J., Gold M.S., de Souza-Brito G., Fisher M.C., Halsey N., et al. Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine 22 (2004) 557-562
20. Bonhoeffer J., Gold M.S., Heijbel H., Vermeer P., Blumberg D., Braun M., et al. Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine 22 (2004) 563-568
21. Bines J.E., Kohl K.S., Forster J., Zanardi L.R., Davis R.L., Hansen J., et al. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 22 (2004) 569-574
22. Rothstein E., Kohl K.S., Ball L., Halperin S.A., Halsey N., Hammer S.J., et al. Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine 22 (2004) 575-585
23. Bonhoeffer J., Vermeer P., Halperin S., Kempe A., Music S., Shindman J., et al. Persistent crying in infants and children as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine 22 (2004) 587-592
24. Bines J.E., Liem N.T., Justice F., Son T.N., Carlin J.B., de Campo M., et al. Validation of a clinical case definition for acute intussusception in infants in Vietnam and Australia. Bull. WHO 84 (2006) 569-575
25. Tapiainen T., Bar G., Bonhoeffer J., and Heininger U. Evaluation of the Brighton Collaboration case definition of acute intussusception during active surveillance. Vaccine 24 (2006) 1483-1487
26. Kohl K.S., Magnus M., Gidudu J., Li J., Halsey N., Ball R., et al. Evaluation of Brighton Collaboration Standardized case definitions: sensitivity, specificity, reliability, and applicability for intussusception, fever, and persistent crying. Poster presentation at International Society of Pharmacoepidemiology (ISPE). Nashville, USA (2005)
27. Kohl K.S., Magnus M., Halsey N., Ball R., and Farley T.A. Comparison of coded case definition criteria with symptom-text narrative in the U.S. Vaccine Adverse Event Reporting System. Poster presentation at International Society of Pharmacoepidemiology (ISPE). Bordeaux, France (2004)